• Prevention of Group B Streptococcal Infection in the Newborn
  • Post-acute COVID-19 Syndrome (PACS)
  • Culture, Feces, Routine, with Campylobacter and Shiga Toxin Antigens, by EIA
  • Idiopathic thrombocytopenic purpura
  • Rett Syndrome
  • Influenza
  • Arrhythmogenic right ventricular dysplasia
  • Hematocrit/Microhematocrit
  • MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • Solute Carrier Organic Anion Transporter Family, Member 1B1 (SLCO1B1) Genotyping, Statin Sensitivity
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
Medical Test

Methodology
Access to MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection is restricted.
Loading...